<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
JAZZ
Jazz Pharmaceuticals
$
()


  • Jazz completes rolling submission of BLA for zanidatamab antibody

    4/2/2024 - 07:34am
  • Jazz Pharmaceuticals price target raised by $17 at Piper Sandler, here's why

    3/20/2024 - 06:58am
  • Jazz Pharmaceuticals price target raised by $5 at Stifel, here's why

    3/15/2024 - 09:22am
  • Zymeworks price target raised by $2 at Wells Fargo, here's why

    3/12/2024 - 06:25am
  • Avadel Pharmaceuticals price target raised by $2 at Needham, here's why

    3/5/2024 - 08:30am
  • Avadel Pharmaceuticals price target raised by $2 at Craig-Hallum, here's why

    3/5/2024 - 08:28am
  • Avadel Pharmaceuticals price target raised by $2 at Oppenheimer, here's why

    3/5/2024 - 07:41am
  • Avadel Pharmaceuticals 'pleased' with ruling in patent litigation with Jazz Pharmaceutica...

    3/4/2024 - 15:41pm
  • Avadel volatility attributed to ruling in patent fight with Jazz Pharmaceuticals

    3/4/2024 - 15:12pm
  • Jazz Pharmaceuticals price target lowered by $5 at Barclays, here's why

    3/1/2024 - 05:39am
  • Jazz Pharmaceuticals price target lowered by $5 at Needham, here's why

    2/29/2024 - 08:53am
  • Jazz Pharmaceuticals price target lowered by $11 at BofA, here's why

    2/29/2024 - 07:48am
  • Jazz Pharmaceuticals sees FY24 adjusted EPS $18.15-$19.35, consensus $19.94

    2/28/2024 - 16:07pm
  • Jazz Pharmaceuticals reports Q4 adjusted EPS $5.02, consensus $5.18

    2/28/2024 - 16:05pm
  • Jazz Pharmaceuticals appoints Philip Johnson as CFO

    2/21/2024 - 07:46am
dynamic_feed Breaking News